Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels.
Fankhauser CD, Wettstein MS, Christiansen AJ, Rothermundt C, Cathomas R, Kaufmann E, Sigg S, Templeton AJ, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Beyer J, Hermanns T. Fankhauser CD, et al. Among authors: rothermundt c. Urol Oncol. 2024 Dec;42(12):455.e9-455.e13. doi: 10.1016/j.urolonc.2024.07.013. Epub 2024 Sep 10. Urol Oncol. 2024. PMID: 39261117 Free article.
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
Fankhauser CD, Christiansen AJ, Rothermundt C, Cathomas R, Wettstein MS, Grossmann NC, Grogg JB, Templeton AJ, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T. Fankhauser CD, et al. Among authors: rothermundt c. Br J Cancer. 2022 May;126(8):1140-1144. doi: 10.1038/s41416-021-01643-z. Epub 2021 Dec 15. Br J Cancer. 2022. PMID: 34912073 Free PMC article.
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence.
Christiansen AJ, Lobo J, Fankhauser CD, Rothermundt C, Cathomas R, Batavia AA, Grogg JB, Templeton AJ, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Moch H, Beyer J, Hermanns T. Christiansen AJ, et al. Among authors: rothermundt c. Front Oncol. 2022 Dec 8;12:1056823. doi: 10.3389/fonc.2022.1056823. eCollection 2022. Front Oncol. 2022. PMID: 36568207 Free PMC article.
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Pratsinis M, Fankhauser C, Pratsinis K, Beyer J, Bührer E, Cathomas R, Fischer N, Hermanns T, Hirschi-Blickenstorfer A, Kamradt J, Alex Kluth L, Zihler D, Mingrone W, Müller B, Nestler T, Rothschild SI, Seifert B, Templeton AJ, Terbuch A, Ufen MP, Woelky R, Gillessen S, Rothermundt C. Pratsinis M, et al. Among authors: rothermundt c. Eur Urol Open Sci. 2022 Apr 26;40:16-18. doi: 10.1016/j.euros.2022.03.013. eCollection 2022 Jun. Eur Urol Open Sci. 2022. PMID: 35515270 Free PMC article.
Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review.
Neuenschwander A, Lonati C, Antonelli L, Papachristofilou A, Cathomas R, Rothermundt C, Templeton AJ, Gulamhusein A, Fischer S, Gillessen S, Hermanns T, Lorch A, Mattei A, Fankhauser CD. Neuenschwander A, et al. Among authors: rothermundt c. Eur Urol Focus. 2023 May;9(3):541-546. doi: 10.1016/j.euf.2022.11.003. Epub 2022 Nov 12. Eur Urol Focus. 2023. PMID: 36379869 Free article. Review.
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Fischer S, Rothermundt C, Stalder O, Terbuch A, Hermanns T, Zihler D, Müller B, Fankhauser CD, Hirschi-Blickenstorfer A, Seifert B, Kluth LA, Ufe MP, Mingrone W, Templeton AJ, Fischer N, Rothschild S, Woelky R, Gillessen S, Cathomas R. Fischer S, et al. Among authors: rothermundt c. Eur Urol Open Sci. 2023 Feb 20;50:57-60. doi: 10.1016/j.euros.2023.01.013. eCollection 2023 Apr. Eur Urol Open Sci. 2023. PMID: 36874175 Free PMC article.
Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C, Thurneysen C, Cathomas R, Müller B, Mingrone W, Hirschi-Blickenstorfer A, Wehrhahn T, Ruf C, Rothschild S, Seifert B, Terbuch A, Grassmugg T, Woelky R, Fankhauser C, Kunit T, Fischer N, Inauen R, Kamradt J, Ziegler K, Haynes A, Jüni P, Gillessen S. Rothermundt C, et al. Swiss Med Wkly. 2018 Jul 24;148:w14640. doi: 10.4414/smw.2018.14640. eCollection 2018. Swiss Med Wkly. 2018. PMID: 30044478 Free article.
Swiss germ-cell cancer consensus recommendations.
Beyer J, Berthold D, Bode PK, Cathomas R, Fankhauser CD, Fischer S, Gillessen S, Gross T, Hermanns T, Honecker F, Lorch A, Omlin A, Papachristofilou A, Roth B, Rothermundt C, Seiler R, Spahn M, Stenner F, Bührer E. Beyer J, et al. Among authors: rothermundt c. Swiss Med Wkly. 2021 Aug 23;151(33-34). doi: 10.4414/SMW.2021.w30023. Swiss Med Wkly. 2021. PMID: 34495606 Free article. Review.
Treatment and follow-up of rare testis tumours.
Fankhauser CD, Grogg JB, Rothermundt C, Clarke NW. Fankhauser CD, et al. Among authors: rothermundt c. J Cancer Res Clin Oncol. 2022 Mar;148(3):667-671. doi: 10.1007/s00432-021-03890-2. Epub 2022 Jan 20. J Cancer Res Clin Oncol. 2022. PMID: 35048196 Review.
82 results